Digitide Solutions Launches 'Pulse.nerve' Enterprise Orchestration Platform

Digitide Solutions Launches 'Pulse.nerve' Enterprise Orchestration Platform

Digitide Solutions Launches 'Pulse.nerve' Enterprise Orchestration Platform​

Bengaluru, March 31, 2026 - Digitide Solutions Limited (NSE: DIGITIDE) announced the launch of Pulse.nerve, a first-of-its-kind enterprise orchestration platform designed to unify fragmented intelligence. The platform is designed to manage, govern, and synchronize AI agents across siloed technology stacks.

The launch of Pulse.nerve is supported by the release of 100+ ready-to-deploy AI agents within the Pulse.ai ecosystem.

Product Details:
S. No.ParticularsDetails
1Name of the ProductPulse.nerve
2Date of LaunchMarch 31, 2026
3Category of the ProductInformation Technology
4Whether caters to domestic/ international marketBoth (Domestic and International)
5Name of the countries in which the product is launched (in case of international).Globally

According to Digitide Solutions CEO & Executive Director, Gurmeet Chahal, Pulse.nerve provides a universal execution layer, moving organizations from fragmented experimentation to a coherent, governed, and high-ROI agentic strategy.

Pulse.nerve utilizes the Model Context Protocol (MCP) and connects to enterprise platforms like Salesforce, SAP, Oracle, ServiceNow, Guidewire, and Duck Creek. Key capabilities include intelligent task routing, an enterprise "kill-switch" for governance, universal compliance enforcement, and 100+ specialized AI agents.

In a recent deployment for a global insurer, Pulse.nerve orchestrated agentic workflows across Guidewire, Salesforce, and Oracle, resulting in a 45% improvement in operational productivity and a 3.4x acceleration in AI time-to-value.

Digitide Solutions Limited is a technology and business transformation partner assisting enterprises with AI-led innovation. The company has 55,000 professionals serving over 300 clients worldwide, generating more than USD 350 million in annual revenue.

Source:​

 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Back
Top